NCT06439355

Brief Summary

The aim of the PI-PEG study is to explore the taste functions of the following 3 groups of participants:

  • healthy volunteers
  • patients with early Parkinson's disease
  • patients with incipient Lewy body disease. To this end, the results obtained from taste evoked potentials in each of the 3 groups of participants will be compared with each other and with different nutritional, motor and cognitive data. This study could reveal a difference in cortical processing of gustatory sensory information between patients who have had idiopathic Parkinson's disease progressing for 3 years or less, and patients who have had Lewy body disease progressing for 3 years or less. Indeed, a modification of taste evoked potentials (in terms of latencies) proportional to the degree of cerebral degeneration could be observed.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 27, 2024

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

May 28, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 3, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

June 7, 2024

Status Verified

June 1, 2024

Enrollment Period

1.9 years

First QC Date

May 28, 2024

Last Update Submit

June 6, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Average latency of taste-evoked potentials

    After a 2-hour fasting period

Study Arms (3)

Healthy volunteers

ACTIVE COMPARATOR
Biological: Fasting blood testOther: Subject interviewOther: Motor assessmentOther: Neurocognitive assessmentOther: Nutritional assessmentOther: Taste tests

Patients with Idiopathic Parkinson's Disease (IPD) of course ≤ 3 years

EXPERIMENTAL
Biological: Fasting blood testOther: Subject interviewOther: Motor assessmentOther: Neurocognitive assessmentOther: Nutritional assessmentOther: Taste tests

Patients with Lewy body disease (LBD) progressing ≤ 3 years

EXPERIMENTAL
Biological: Fasting blood testOther: Subject interviewOther: Motor assessmentOther: Neurocognitive assessmentOther: Nutritional assessmentOther: Taste tests

Interventions

metabolic assays determination of food intake hormones oxidative stress and neurodegeneration marker assays

Healthy volunteersPatients with Idiopathic Parkinson's Disease (IPD) of course ≤ 3 yearsPatients with Lewy body disease (LBD) progressing ≤ 3 years

socio-demographic data, medical and family history, treatment taken

Healthy volunteersPatients with Idiopathic Parkinson's Disease (IPD) of course ≤ 3 yearsPatients with Lewy body disease (LBD) progressing ≤ 3 years

MDS-UPDRS scale PART III

Healthy volunteersPatients with Idiopathic Parkinson's Disease (IPD) of course ≤ 3 yearsPatients with Lewy body disease (LBD) progressing ≤ 3 years

MoCA and MMSE scales

Healthy volunteersPatients with Idiopathic Parkinson's Disease (IPD) of course ≤ 3 yearsPatients with Lewy body disease (LBD) progressing ≤ 3 years

anthropometric data (weight, height, BMI, waist circumference, hip circumference, android/gynoid ratio, triceps skin fold, brachial circumference), bioelectrical impedancemetry (fat mass, lean mass, water mass and bone mass)

Healthy volunteersPatients with Idiopathic Parkinson's Disease (IPD) of course ≤ 3 yearsPatients with Lewy body disease (LBD) progressing ≤ 3 years

Recording of PEGs in response to a sucrose solution and a free fatty acid solution (prepared beforehand)

Healthy volunteersPatients with Idiopathic Parkinson's Disease (IPD) of course ≤ 3 yearsPatients with Lewy body disease (LBD) progressing ≤ 3 years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy volunteers:
  • Person who has given written consent
  • Adult
  • Enrolled in the national register of healthy volunteers
  • Fasting \> 2 hours before PEG measurement
  • Body Mass Index (BMI) \< 30 kg/m².
  • No cognitive complaints and normal neurological assessment
  • Patients with idiopathic Parkinson's disease:
  • Person who has given written consent
  • Adult
  • Fasting \> 2 hours before PEG measurement
  • Body Mass Index (BMI) \< 30 kg/m².
  • Diagnostic criteria for established or probable IPD
  • Patients with Lewy body disease:
  • Person who has given written consent
  • +4 more criteria

You may not qualify if:

  • Non-affiliated to national health insurance
  • Person under legal protection (curatorship, guardianship)
  • Person subject to a court order
  • Pregnant, parturient or breast-feeding women
  • Major unable to give consent
  • MMSE score \< 15 and/or MoCA \< 10
  • Active smoker (\> 4 cigarettes per day on a regular basis)
  • Subject with pacemaker (contraindication for bioelectrical impedancemetry)
  • Diabetic (type 1 or type 2)
  • Taking medication (in progress at the time of the study) that interferes with gustation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chu Dijon Bourgogne

Dijon, France

RECRUITING

MeSH Terms

Conditions

Parkinson DiseaseLewy Body Disease

Interventions

Mental Status and Dementia TestsNutrition Assessment

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesDementiaNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Neuropsychological TestsPsychological TestsBehavioral Disciplines and ActivitiesData CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationEpidemiologic MeasurementsPublic HealthEnvironment and Public Health

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 28, 2024

First Posted

June 3, 2024

Study Start

May 27, 2024

Primary Completion

May 1, 2026

Study Completion

May 1, 2026

Last Updated

June 7, 2024

Record last verified: 2024-06

Locations